🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — my results so far Page 5

Nausea incidence by dose tier — my results so far

MikeFit_NJ Fri, Apr 26, 2024 at 7:15 AM 52 replies 2,374 viewsPage 5 of 11
ChrisMacros
Member
567
2,345
Sep 2024
Michigan
Apr 26, 2024 at 2:20 PM#21

Congrats MikeFit_NJ!! Keep going — you're doing incredible. 🎉

24 10RunnerRach, TrialNerd_Beth, HPLC_Greg and 21 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Apr 26, 2024 at 2:37 PM#22

Reading this thread on Nausea incidence by dose hits close to home. Night shift nurse — I started at 271 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 46 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Nausea incidence by — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Apr 26, 2024 at 5:37 PM
41 6hank_denver, carlos_SATX, sophie_paris and 38 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Apr 26, 2024 at 2:54 PM#23

As a pharmacist, I want to add some clinical context to this discussion on Nausea incidence by dose tier my.

Building on what ChrisMacros said — the evidence base here is robust. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
13 7SteveThurs, B12Beth, RickReta_CO and 10 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
Apr 26, 2024 at 3:11 PM#24

SleepDoc_PDX — wow. I've been looking for this exact info for weeks.

6 4CanadaChris, ZaraB_AL, JakeSmashed95 and 3 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Apr 26, 2024 at 3:28 PM#25

Adding my data to this Nausea incidence by dose discussion:

MetricBaselineMonth 5Month 6
Weight264 lbs239 lbs209 lbs
A1C6.8%6.0%5.2%
hsCRP8.04.00.6

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.6g/kg/day.

Last edited: Apr 26, 2024 at 7:28 PM
12 21DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 9 others
Reply Quote Save Share Report
13456711

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register